How much people are willing to spend

How much people are willing to spend

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Demand for weight loss drugs is booming in the U.S. despite their limited insurance coverage and roughly $1,000 monthly price tags before discounts.  But some patients are willing to pay more out of … Read more

Medicare can cover weight loss drugs if used for added health benefit

Medicare can cover weight loss drugs if used for added health benefit

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Medicare can start covering certain weight loss drugs for the first time – as long as they are approved for an added health benefit, the Centers for Medicare and Medicaid Services said Thursday. … Read more

Wegovy heart health approval won’t mean broad insurance coverage yet

Wegovy heart health approval won’t mean broad insurance coverage yet

Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of … Read more

Wegovy heart health approval won’t mean broad insurance coverage yet

Wegovy heart health approval won’t mean broad insurance coverage yet

Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of … Read more

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen.  Rafael Henrique | SOPA Images | Lightrocket | Getty Images The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide. The FDA’s decision means Madrigal Pharmaceuticals … Read more

Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs

Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients’ homes through the drugmaker’s new direct-to-consumer program.  Starting Wednesday, … Read more

Pfizer is betting big on cancer drugs after Covid decline

Pfizer is betting big on cancer drugs after Covid decline

Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid.  Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. It just might take a while before that bet pays off.  Pfizer pitched its … Read more

Weight loss pill could become a best-in-class drug

Weight loss pill could become a best-in-class drug

Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become a best-in-class treatment for obesity.  The Danish drugmaker is racing to capitalize on the runaway success of its blockbuster weight loss drug Wegovy by developing a new generation of treatments for obesity, including more convenient and … Read more

Eli Lilly Alzheimer’s drug FDA approval delayed

Eli Lilly Alzheimer’s drug FDA approval delayed

Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty … Read more

Cigna to cap employer insurance plan spending

Cigna to cap employer insurance plan spending

Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Cigna on Thursday unveiled a new effort to expand insurance coverage for weight loss drugs by limiting how much health plans and employers spend on the highly popular treatments each year.  … Read more